Weiler Kathy Johnson 4

What Happened

• Kathy Weiler (listed as Weiler Kathy Johnson), a director of Axogen, exercised 16,344 stock options and immediately sold those 16,344 shares in the open market on May 7, 2026. The exercise cost was $6.95 per share (total ~$113,591); the shares were sold at a weighted-average price of $44.09 per share for proceeds of about $720,623. This is a sale (a routine monetization of vested options), not a purchase.

Key Details

• Transaction date: May 7, 2026; Form 4 filed May 8, 2026 (timely).
• Exercise: 16,344 shares exercised at $6.95/share = $113,591 (derivative code M).
• Sale: 16,344 shares sold in the open market at a weighted-average $44.09/share = ~$720,623 (code S). Sale prices ranged $44.04–$44.26 (see footnote F1).
• Post-transaction shares owned: not specified in the provided excerpt of the filing.
• Footnotes: F1 notes the weighted-average sale price and per-trade price range; F2 indicates the options were granted as a board-joining award that vests in three equal annual installments beginning Dec 20, 2024.
• Filing timeliness: filed the next day (no late filing indicated).

Context

• This was essentially a cashless exercise — director exercised vested options and sold the resulting shares the same day to realize proceeds. Such transactions are common for directors monetizing vested grants and do not, by themselves, indicate broader company guidance or a change in insider sentiment.